Pieris Pharmaceuticals Inc (PIRS)
17.20
-0.10
(-0.58%)
USD |
NASDAQ |
Nov 04, 12:57
Pieris Pharmaceuticals Price to Book Value: 1.214 for Nov. 4, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 1.221 |
| October 31, 2024 | 1.218 |
| October 30, 2024 | 1.191 |
| October 29, 2024 | 1.200 |
| October 28, 2024 | 1.200 |
| October 25, 2024 | 1.196 |
| October 24, 2024 | 1.200 |
| October 23, 2024 | 1.196 |
| October 22, 2024 | 1.159 |
| October 21, 2024 | 1.186 |
| October 18, 2024 | 1.194 |
| October 17, 2024 | 1.195 |
| October 16, 2024 | 1.164 |
| October 15, 2024 | 1.147 |
| October 14, 2024 | 1.148 |
| October 11, 2024 | 1.168 |
| October 10, 2024 | 1.154 |
| October 09, 2024 | 1.141 |
| October 08, 2024 | 1.132 |
| October 07, 2024 | 1.142 |
| October 04, 2024 | 1.148 |
| October 03, 2024 | 1.150 |
| October 02, 2024 | 1.168 |
| October 01, 2024 | 1.172 |
| September 30, 2024 | 1.170 |
| Date | Value |
|---|---|
| September 27, 2024 | 1.141 |
| September 26, 2024 | 1.141 |
| September 25, 2024 | 1.164 |
| September 24, 2024 | 1.205 |
| September 23, 2024 | 1.214 |
| September 20, 2024 | 1.217 |
| September 19, 2024 | 1.199 |
| September 18, 2024 | 1.141 |
| September 17, 2024 | 1.169 |
| September 16, 2024 | 1.172 |
| September 13, 2024 | 1.177 |
| September 12, 2024 | 1.202 |
| September 11, 2024 | 1.234 |
| September 10, 2024 | 1.203 |
| September 09, 2024 | 1.230 |
| September 06, 2024 | 1.203 |
| September 05, 2024 | 1.218 |
| September 04, 2024 | 1.242 |
| September 03, 2024 | 1.232 |
| August 30, 2024 | 1.299 |
| August 29, 2024 | 1.304 |
| August 28, 2024 | 1.210 |
| August 27, 2024 | 1.254 |
| August 26, 2024 | 1.294 |
| August 23, 2024 | 1.275 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.404
Minimum
Jun 30 2023
11.00
Maximum
Dec 02 2019
3.221
Average
3.228
Median
Mar 17 2023
Price to Book Value Benchmarks
| Ligand Pharmaceuticals Inc | 2.589 |
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | -- |
| iBio Inc | 1.114 |
| Theriva Biologics Inc | 0.0745 |
Price to Book Value Related Metrics
| PS Ratio | 0.5262 |
| Price | 17.20 |
| Earnings Yield | -108.8% |
| Market Cap | 22.71M |